Talphera TLPH
NASDAQ TLPH
$1.20 +0.00 (+0.42%)
As of: Aug 20, 2026 · 3:59 PM EDT

Talphera (TLPH) Long-Term Debt Issuances (2011)

Talphera (TLPH) posted quarterly Long-Term Debt Issuances of $10.0 million for Q4 2011.

Talphera (TLPH) Long-Term Debt Issuances (2011) Analysis & Trends

Talphera's Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at $10.0 million for Q4 2011.

  • In Q4 2011, Long-Term Debt Issuances changed N/A year-over-year to $10.0 million; the TTM figure through Sep 2019 stood at $10.0 million (changed N/A YoY), while the FY2019 annual figure was $25.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q4 2011 stood at $10.0 million.
  • The five-year high for Long-Term Debt Issuances was $10.0 million in Q4 2011, with the low at $10.0 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Talphera 90.63 Mn 90.63 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2011 10.00 Mn
Dec 31, 2011 10.00 Mn